CHICAGO, Nov. 25, 2022 /PRNewswire/ -- HPV Testing and Pap Test Market is projected to reach USD 9.2 billion by 2027 from USD 4.9 billion in 2022, at a CAGR of 13.2% according to a new report by MarketsandMarkets. Development of new cervical cancer diagnostic products and, government support boosting the market. Emerging economies such as India and Japan are providing lucrative opportunities for the players operating in the HPV testing and Pap test market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=214207371
Browse in-depth TOC on "HPV Testing and Pap Test Market"
211 - Tables
35 - Figures
180 - Pages
The HPV testing segment accounted for the largest share of the HPV testing and Pap test market, by test type segment, in 2021
Based on test type, the HPV testing and Pap test market is segmented into HPV Testing and Pap Test. The HPV testing segment accounted for the largest share of the HPV testing and Pap test market, mainly due to the growth of cervical cancer diagnostics products market.
The cervical cancer screening segment accounted for the largest share of the HPV testing and Pap test market, by test type segment, in 2021
Based on application, the HPV testing and Pap test market is segmented into cervical cancer screening and vaginal cancer screening. The cervical cancer screening segment accounted for the largest share of the HPV testing and Pap test market, mainly due to the growth of public awareness about cervical cancer.
Hospitals companies segment to register the highest growth rate during the forecast period
The HPV testing and Pap test market is segmented into laboratories, hospitals and physician's offices & clinics based on end user. In 2021, the hospitals segment accounted for the largest share of the HPV testing and Pap test market. The large share of this segment can mainly be attributed to the investment in the biotech and pharmaceutical industry.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=214207371
North America is the largest regional market for HPV testing and Pap test market
The global HPV testing and Pap test market is segmented into five major regions-North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest regional market for HPV testing and Pap test market in 20201. The large share of North America in this market can be attributed to the governments support for cancer research in the region.
The major players operating in this market are Abbott Laboratories (US), Roche Diagnostics (Switzerland), Becton, Dickinson and Company (US), Hologic, Inc. (US), Quest Diagnostics (US), Qiagen N.V. (Netherland), Seegene, Inc. (US), Femasys, Inc. (US), Arbor Vita Corporation (US) and Mylab Discovery Solutions Pvt. Ltd. (India).
Development of new cervical cancer diagnostic products and, government support boosting the market. Emerging economies such as India and Japan are providing lucrative opportunities for the players operating in the HPV testing and Pap test market.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=214207371
Browse Adjacent Market: Medical Devices Market Research Reports & Consulting
Related Reports:
Infectious Disease Diagnostics Market - Global Forecasts to 2027
Molecular Diagnostics Market - Global Forecasts to 2027
Veterinary Infectious Disease Diagnostics Market - Global Forecasts to 2026
Companion Diagnostics Market - Global Forecasts to 2026
Womens Health Diagnostics Market - Global Forecasts to 2025
About MarketsandMarkets:
MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/hpv-testing-pap-test-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/hpv-testing-pap-test.asp
Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/hpv-testing-and-pap-test-market-worth-9-2-billion-by-2027---exclusive-report-by-marketsandmarkets-301687092.html
